FDA

News

Update: J&J COVID vaccine rollout paused as clot concerns sp...

US health authorities have recommended pausing dosing with Johnson & Johnson's COVID-19 vaccine as they investigate cases of blood clots also observed in some people taking the AstraZen

News

Provention faces delay in FDA review of diabetes prevention ...

The FDA says it has uncovered "deficiencies" in the marketing application for Provention Bio's much-anticipated drug teplizumab for the prevention of

News

Acadia puts blame on FDA as Nuplazid rejected for dementia

Acadia Pharmaceuticals is butting heads with US regulators again, this time over the FDA’s decision to reject its Nuplazid (pimavanserin) for use in dementia-related psychosis (DRP) – with the c

News

FDA green lights Oxehealth vital signs monitoring software

UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed.

Events

Partner Content

6th CAR-TCR Summit 2021

6th CAR-TCR Summit - Aug 30 - Sep 2, 2021

News

Merck gets confirmatory trial win for Keytruda in endometria...

Merck & Co’s conditional FDA approval for checkpoint inhibitor Keytruda in endometrial cancer looks secure, thanks to a survival benefit in a confirmatory phase 3 trial.

Update: J&J COVID vaccine rollout paused as clot concerns sp...

Provention faces delay in FDA review of diabetes prevention ...

Acadia puts blame on FDA as Nuplazid rejected for dementia

FDA green lights Oxehealth vital signs monitoring software

6th CAR-TCR Summit 2021

Merck gets confirmatory trial win for Keytruda in endometria...

AI-enabled pharmacovigilance, with Updesh Dosanjh

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks